Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments

Knowledge of the molecular mechanisms on malignant tumors is very critical for the development of new treatment strategies like molecularly targeted therapies. In last 5 years, many investigations suggest that stathmin is over-expressed in a variety of human malignant tumors, and potentially promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Biaoxue, Rong, Xiguang, Cai, Hua, Liu, Shuanying, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037901/
https://www.ncbi.nlm.nih.gov/pubmed/27670291
http://dx.doi.org/10.1186/s12967-016-1000-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037901/
https://www.ncbi.nlm.nih.gov/pubmed/27670291
http://dx.doi.org/10.1186/s12967-016-1000-z

Ejemplares similares